An expanded universe of cancer targets
William C Hahn,Joel S Bader,Theodore P Braun,Andrea Califano,Paul A Clemons,Brian J Druker,Andrew J Ewald,Haian Fu,Subhashini Jagu,Christopher J Kemp,William Kim,Calvin J Kuo,Michael McManus,Gordon B Mills,Xiulei Mo,Nidhi Sahni,Stuart L Schreiber,Jessica A Talamas,Pablo Tamayo,Jeffrey W Tyner,Bridget K Wagner,William A Weiss,Daniela S Gerhard,Cancer Target Discovery and Development Network,Vlado Dancik,Shubhroz Gill,Bruce Hua,Tanaz Sharifnia,Vasanthi Viswanathan,Yilong Zou,Filemon Dela Cruz,Andrew Kung,Brent Stockwell,Jesse Boehm,Josh Dempster,Robert Manguso,Francisca Vazquez,Lee A D Cooper,Yuhong Du,Andrey Ivanov,Sagar Lonial,Carlos S Moreno,Qiankun Niu,Taofeek Owonikoko,Suresh Ramalingam,Matthew Reyna,Wei Zhou,Carla Grandori,Ilya Shmulevich,Elizabeth Swisher,Jitong Cai,Issac S Chan,Matthew Dunworth,Yuchen Ge,Dan Georgess,Eloïse M Grasset,Elodie Henriet,Hildur Knútsdóttir,Michael G Lerner,Veena Padmanaban,Matthew C Perrone,Yasir Suhail,Yohannes Tsehay,Manisha Warrier,Quin Morrow,Tamilla Nechiporuk,Nicola Long,Jennifer Saultz,Andy Kaempf,Jessica Minnier,Cristina E Tognon,Stephen E Kurtz,Anupriya Agarwal,Jordana Brown,Kevin Watanabe-Smith,Tania Q Vu,Thomas Jacob,Yunqi Yan,Bridget Robinson,Evan F Lind,Yoko Kosaka,Emek Demir,Joseph Estabrook,Michael Grzadkowski,Olga Nikolova,Ken Chen,Ben Deneen,Han Liang,Michael C Bassik,Asmita Bhattacharya,Kevin Brennan,Christina Curtis,Olivier Gevaert,Hanlee P Ji,Kasper A J Karlsson,Kremena Karagyozova,Yuan-Hung Lo,Katherine Liu,Michitaka Nakano,Anuja Sathe,Amber R Smith,Kaitlyn Spees,Wing Hing Wong,Kanako Yuki,Matt Hangauer,Dan S Kaufman,Allan Balmain,Saumya R Bollam,Wei-Ching Chen,QiWen Fan,Kelly Kersten,Matthew Krummel,Yun Rose Li,Marie Menard,Nicole Nasholm,Christin Schmidt,Nina K Serwas,Hiroyuki Yoda
DOI: https://doi.org/10.1016/j.cell.2021.02.020
IF: 64.5
2021-03-04
Cell
Abstract:The characterization of cancer genomes has provided insight into somatically altered genes across tumors, transformed our understanding of cancer biology, and enabled tailoring of therapeutic strategies. However, the function of most cancer alleles remains mysterious, and many cancer features transcend their genomes. Consequently, tumor genomic characterization does not influence therapy for most patients. Approaches to understand the function and circuitry of cancer genes provide complementary approaches to elucidate both oncogene and non-oncogene dependencies. Emerging work indicates that the diversity of therapeutic targets engendered by non-oncogene dependencies is much larger than the list of recurrently mutated genes. Here we describe a framework for this expanded list of cancer targets, providing novel opportunities for clinical translation.